XML 86 R74.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes, Deferred Tax Assets (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Deferred Tax Assets [Abstract]            
Net operating loss carryforwards $ 38,323,000 $ 33,238,000        
Net operating loss carryforwards - foreign 24,000 23,000        
Excess of tax basis over book value of property and equipment 9,000 14,000        
Excess of tax basis over book value of intangible assets 1,325,000 1,622,000        
Lease liability 150,000 96,000        
Stock-based compensation 1,487,000 1,613,000        
Accrued employee compensation 750,000 698,000        
Capitalized equity costs 0 49,000        
Capitalized research and development 116,000 0        
Net change in reserve accounts 1,031,000 898,000        
Gross deferred tax assets 43,215,000 38,251,000        
Valuation Allowance (43,070,000) (38,165,000)        
Net Deferred Tax Asset 145,000 86,000        
Deferred Tax Liabilities, Net [Abstract]            
Right-of-use asset (145,000) (86,000)        
Gross deferred tax liability (145,000) (86,000)        
TOTAL 0 0        
Capitalized R&D costs 600,000          
Income Tax Penalties and Interest Expense [Abstract]            
Income tax penalties 0 0        
Interest on income taxes $ 0 0        
Earliest Tax Year [Member]            
Operating Loss Carryforwards [Abstract]            
Operating loss carryforwards, expiry date Dec. 31, 2024          
Latest Tax Year [Member]            
Operating Loss Carryforwards [Abstract]            
Operating loss carryforwards, expiry date Dec. 31, 2025          
U.S. Federal [Member]            
Deferred Tax Liabilities, Net [Abstract]            
Capitalized R&D, amortization period 5 years          
Operating Loss Carryforwards [Abstract]            
Net operating loss carryforwards           $ 159,700,000
Operating loss carryforwards, expiry date Dec. 31, 2042          
Operating loss carryforwards limited with no expiration $ 81,800,000 $ 81,800,000 $ 81,800,000 $ 81,800,000 $ 81,800,000  
Outside U.S. [Member]            
Deferred Tax Liabilities, Net [Abstract]            
Capitalized R&D, amortization period 15 years          
Operating Loss Carryforwards [Abstract]            
Net operating loss carryforwards $ 100,000          
State [Member]            
Operating Loss Carryforwards [Abstract]            
Operating loss carryforwards limited with no expiration $ 70,500,000